A comparative study of the use of combinations of fumagillin and tetracycline or erthromycin in the treatment of intestinal amebiasis; a preliminary report.
D000562:Amebiasis; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003510:Cyclohexanes; D004404:Dysentery, Amebic / Q000628:therapy*; D004917:Erythromycin / Q000627:therapeutic use*; D005231:Fatty Acids, Unsaturated; D012717:Sesquiterpenes; D013752:Tetracycline / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D003510:Cyclohexanes; D005231:Fatty Acids, Unsaturated; D012717:Sesquiterpenes; D004917:Erythromycin; C026211:fumagillin; D013752:Tetracycline
AMEBIASIS, INTESTINAL/therapy; ANTIBIOTICS/therapeutic use; ERYTHROMYCIN/therapeutic use; TETRACYCLINE/therapeutic use